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Doxycycline and Eradication of
Microfilaremia in Patients with Loiasis
To the Editor: Wolbachia are intracellular symbionts found
in 20% of insects and in several nematodes, including filarial
worms. Because tetracycline eradicates Wolbachia in nema-
todes, this drug has been proposed for chemotherapy in
filariasis (1). We report two patients with loiasis in whom
no Wolbachial DNA was detected in microfilariae by poly-
merase chain reaction (PCR), and for whom 6 weeks of
doxycycline failed to eradicate the microfilaremia. We conclude
that doxycycline may not be an efficient therapy for loiasis.
Filariae are responsible for 150 million infections
worldwide, some of them devastating diseases such as
elephantiasis (caused by Bancroftian and Brugian filaria-
sis) and blindness (caused by onchocerciasis). There is no
satisfactory treatment for filariasis: although diethycarbam-
azine citrate has been used for 50 years to treat the disease,
this drug is not efficient in most adults (2). Ivermectin has
been reported to be efficient in treating microfilaremia and
possibly for viability and fertility of adult Oncocerca volvulus
worms if therapy is prolonged for 2 to 3 years (2). However,
the microfilaricidal effect of ivermectin on Wuchereria,
Brugia, and Loa loa is similar to diethycarbamazine: ultra-
sonography shows that it has no effect on adult Bancroftian
worms, and microfilariae often reappear after a few months (2).
Intracellular bacteria have been observed in the lateral
cords of adult female worms as well as in microfilariae of
W. bancrofti, and these bacteria have recently been identi-
fied as belonging to the Wolbachia genogroup (3). Wolbachia
have been detected by PCR in Brugian and Bancroftian
filariae, dirofilariae, and most species of Oncocerca includ-
ing O. volvulus, but have never been detected in L. loa
worms (4). Wolbachia are causative agents of a variety of
modifications in host development and reproduction,
including cytoplasmic incompatibility and parthenogenesis.
Consequently, it has been proposed that antibiotic eradica-
tion of Wolbachia from infected filarial worms would reduce
microfilaremia. This has been demonstrated in an animal
model with Litomosoides sigmodontis and recently
confirmed in patients infected with O. volvulus (1-5). In
experimental L. sigmodontis infection, after 41 days of
therapy, microfilaremia in tetracycline-treated animals was
one-tenth that in normally infected animals (5).
We report the failure of tetracycline to reduce microfila-
remia in two patients with L. loa filariasis. Patient no. 1
was a 58-year-old man who worked in Gabon for many
years and had cutaneous larva migrans. L. loa microfilare-
mia was detected (4x103/mL). Patient no. 2, a 15-year-old
boy living in Cameroon, was diagnosed with Calabar
swelling with L. loa microfilaremia (1x103/mL). After giving
informed consent, both patients were treated with doxycy-
cline 200 mg daily for 6 weeks as previously described in
O. volvulus-infected patients (1). We observed patients for
microfilaremia every week for 6 weeks and then every 2
weeks for 2 months. The presence of adult worms was
detected by physical examinations.
 Microfilaremia was detected in both patients at the
completion of treatment and at day 120 of follow-up. In
patient no. 1, the frequency of migrating adult worms
seemed to diminish during therapy, but they never disap-
peared. For Wolbachia detection in worms, blood samples
were collected both in Dupont-Isolator and EDTA-contain-
ing tubes. After centrifugation at 5000 x g for 30 min, the
worm-enriched pellet was resuspended in 1 mL of sterile
deionized water for erythrocyte lysis. DNA was extracted
from the suspension by using the QIAmp-blood kit (Qiagen,
Hilden, Germany) following manufacturer’s recommenda-
tions. W. pipientis DNA was used as a positive control.
Control of DNA extraction was performed by amplifying
microfilarial DNA using the nematode-specific 18S r DNA-
derived primers 18SF (5'-GAT-ACC-GCC-CTA-GTT-CTG-
ACC-3') and 18SR (5'-ACC-AAC-TAA-GAA-CGG-CCA-TG-
3'). Wolbachia detection was attempted with the FD1 (5'-
AGA-GTT-TGA-TCC-TGG-CTC-AG-3') and Rp2 (5'-ACG-
GCT-ACC-TTG-TTA-CGA-CTT-3') eubacterial primers, with
the Ehrlichia genus-specific 16S rDNA primers EHR16SD
(5'-GGT-ACC-YAC-AGA-AGA-AGT-CC-3') and EHR16SR
(5'- TAG-CAC-TCA-TCG-TTT-ACA-GC-3'), and with primers
specific for the 16S r DNA of B. malayi endosymbiont, Bsymbf
(5'-ACG-AGT-TAT-AGT-ATA-ACT-3'), and Bsymbr (5'-CCT-
TCG-AAT-AGG-AAT-AAT-3') (3-6). PCR reactions were
performed on PTC-200 thermocycler (MJ-Research, USA) by
using 45 cycles of denaturation at 94°C for 30 sec, hybrid-
ization for 45 sec, and elongation at 72°C for 1 min. Hybrid-
ization temperatures were 55°C for FD1/Rp2, 53°C for
EHR16SD/ EHR16SR, 42°C for Bsymbf/Bsymbr, and 57°C for
18SF/18SR. Experiments were repeated three times.
We detected Wolbachia in the positive control and 18s
rRNA of the nematode in the sample, but no signal compati-
ble with Wolbachial DNA was obtained with the sets of
primers used. In fact, four species of filariae (Dipetalonema
setariosum, Acanthocheilonema vitae, O. flexuosa, and
L. loa) tested for intracellular bacteria by electron microsco-
py, immunohistochemistry, or PCR had no bacteria (4). The
absence of Wolbachia in L. loa microfilariae may explain
the failure of tetracycline therapy in our patients.
More work is needed to determine the prevalence of
Wolbachia in filariae, their impact on fertility in each
species, and the use of antibacterial agents for eradicating
these pathogens.
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Bovine Spongiform Encephalopathy and
Variant Creutzfeldt-Jakob Disease
To the Editor: The article by Brown et al. (1) contains the
statement “it appears likely that changes in the rendering
process that had taken place around 1980 allowed the
etiologic agent in infected carcasses to survive.” If that is
the case, why not revert to the rendering methods used
before 1980? That measure would seem more cost-effective
than trade embargoes and mass killing of cattle. Meal made
from meat and bone was used as a livestock feed additive in
many countries without the apparent disastrous effect seen
in the United Kingdom. Did the rendering methods remain
unchanged in these other countries? Historically, rendering
was viewed somewhat differently in continental Europe; the
primary purpose was not to make animal feed but to destroy
infectious agents, as indicated by the very name of the facility:
destruction plant (Destruktionsanstalt). The plants were
under governmental inspection and there were mandatory
time-temperature requirements for processing meat, bones,
and other offal. Temperature requirements varied from 120°C
to 140°C, which presumably would reduce if not eliminate
prions. It would be of interest to see a description and objective
analysis of rendering methods and regulations in various
countries before and after 1980. In these times when the
concept of hazard analysis and critical control points
(HACCP) is gaining popularity, it would seem natural to
extend the principle of process control to rendering. One
might easily get the impression that policies to control
bovine spongiform encephalitis are dominated by some of
the stakeholders: the researchers writing their next re-
search grant proposals, the public agencies eager to show
prompt response, and those who would like to see their
competitors’ beef kept off the market.
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Mad Cow Disease
To the Editor: In regards to “Bovine Spongiform Encephal-
opathy and  Variant Creutzfeldt-Jakob Disease: Back-
ground, Evolution, and Current Concerns” (1), use of the
name “variant Creutzfeldt-Jacob disease” (vCJD) for human
cases of bovine spongiform encephalopathy (BSE) is regret-
table. The disease that occurs in humans exposed to BSE is
zoonotic and CJD is not; in addition, the human form of
BSE has important clinical, pathologic, and epidemiologic
differences from CJD. Continued use of this terminology
perpetuates the error.
The fact that 12 years after the feed ban bovine cases
continue to occur in the United Kingdom at a much higher
rate than in any other country could have two possible
causes: inefficient controls or additional routes of transmis-
sion. Data on alternative routes of transmission must be
evaluated, and important gaps in our understanding of BSE
in cattle must be addressed.
Extensive epidemiologic data on BSE in the United
Kingdom seemed to clearly implicate the practice of feeding
cattle bovine offal as the primary, if not the sole, cause of
the spread of BSE. Alternative theories for the origin and
spread of BSE, e.g., use of insecticides on bovines or the
practice of artificial insemination, appear to have been
ruled out quickly on the basis of early epidemiologic data.
Confidence in the reliability of these data seems to have
been so great as to unduly delay transmission experiments
to assess the role of alternative pathways (e.g., artificial
insemination) in the propagation of BSE. Is prion protein
present in semen or is it not? What if it were present in
semen? Would this route lead to shorter incubation than the
alimentary route? There seems to be no experimental
information on the effect of freezing mutated prion protein
to -196°C and placing it, after thawing, directly on the
stimulated uterine mucosa.
Although the United Kingdom has acknowledged that
compliance with the feed ban improved after 1996, we
should not be too eager to accept lack of compliance as the
only possible reason for the persistence of BSE. Fifteen
years after the BSE epidemic began, it cannot be disputed
that the ban on offal feed has interrupted spread of the
disease. However, if continued spread by the alimentary
route can be excluded as the cause of more recent cases, each
of these cases should be carefully evaluated to uncover hereto-
fore unknown or underappreciated routes of transmission.
Werner Slenczka
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